← Open Payments lookup

TELATHA SURUJNATH: Open Payments

NPI 1588009047 · LAKEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,824 in 155 payments from 15 companies in 2025. Trend: 2023 $1,222 · 2024 $1,467 · 2025 $1,824

Food & beverage: $1,824
CompanyPaymentsAmount
ABBVIE INC.32$452
Neurocrine BioSciences, Inc.30$263
Otsuka America Pharmaceutical, Inc.21$203
Axsome Therapeutics, Inc.16$183
E.R. Squibb & Sons, L.L.C.16$160
Alkermes, Inc.14$135
Teva Pharmaceuticals USA, Inc.5$85
Supernus Pharmaceuticals, Inc.5$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$68
Neos Therapeutics, LP3$54

Products named: VRAYLAR, INGREZZA, REXULTI, COBENFY, Auvelity, LYBALVI, AUSTEDO XR, Sunosi.

Industry payments across NJ — which companies pay providers there.